Anixa Biosciences Inc (ANIX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 104 transactions totaling $3.0M, demonstrating a bullish sentiment with $2.9M in net insider flow. The most recent transaction on Jan 28, 2026 involved a purchase of 10,000 shares valued at $30.4K.
No significant insider buying has been recorded for ANIX in the recent period.
No significant insider selling has been recorded for ANIX in the recent period.
Based on recent SEC filings, insider sentiment for ANIX is bullish with an Insider Alignment Score of 99/100 and a net flow of $2.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Anixa Biosciences Inc (ANIX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading ANIX stock, having executed 104 transactions in the past 90 days. The most active insider is Amit Kumar (Executive), who has made 26 transactions totaling $6.1M.
Get notified when executives and directors at ANIX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | M. Baskies Arnold | Executive | Purchase | 10,000 | $3.04 | $30.4K | |
| Jan 5, 2026 | M. Baskies Arnold | Executive | Award | 25,000 | $N/A | $0 | |
| Jan 5, 2026 | Catelani Michael | President, COO & CFO | Award | 175,000 | $N/A | $0 | C-Suite |
| Jan 5, 2026 | Gottschalk Emily | Executive | Award | 25,000 | $N/A | $0 | |
| Jan 5, 2026 | Kumar Amit | Executive | Award | 350,000 | $N/A | $0 | |
| Jan 5, 2026 | H. Titterton Lewis Jr | Executive | Award | 25,000 | $N/A | $0 | |
| Dec 15, 2025 | H. Titterton Lewis Jr | Executive | Option Exercise | 16,000 | $2.92 | $46.7K | |
| Oct 30, 2025 | Kumar Amit | Executive | Option Exercise | 200,000 | $2.92 | $584.0K | Large |
| Oct 30, 2025 | Kumar Amit | Executive | Payment | 169,439 | $4.06 | $687.9K | Large |
| Jul 31, 2025 | H. Titterton Lewis Jr | Executive | Purchase | 10,000 | $3.08 | $30.8K | |
| Jul 30, 2025 | Kumar Amit | Executive | Purchase | 5,000 | $3.16 | $15.8K | |
| Jul 18, 2025 | M. Baskies Arnold | Executive | Purchase | 5,000 | $3.39 | $16.9K | |
| Jul 11, 2025 | Kumar Amit | Executive | Purchase | 5,000 | $3.15 | $15.8K | |
| Jul 11, 2025 | H. Titterton Lewis Jr | Executive | Purchase | 10,000 | $3.14 | $31.4K | |
| Jul 31, 2024 | H. Titterton Lewis Jr | Executive | Purchase | 5,580 | $3.23 | $18.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 4 | $3.3M | 35.5% |
Purchase(P) | 72 | $3.0M | 31.9% |
Exercise(M) | 9 | $3.0M | 31.8% |
Sale(S) | 1 | $42.1K | 0.5% |
Other(J) | 8 | $23.8K | 0.3% |
Award(A) | 8 | $9.0K | 0.1% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at Anixa Biosciences Inc are accumulating shares at an accelerated pace. With 7 insiders making 104 transactions totaling $3.0M in purchases versus $42.1K in sales, the net buying activity of $2.9M signals strong executive confidence. Amit Kumar (Executive) leads the buying activity with $6.1M in transactions across all time.